Arkansas § 20-7-707 Prescriber requirements

Arkansas Statutes

§ 20-7-707 — Prescriber requirements

Arkansas § 20-7-707

Title20

This text of Arkansas § 20-7-707 (Prescriber requirements) is published on Counsel Stack Legal Research, covering Arkansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ark. Code Ann. § 20-7-707 (2026).

Text

(a)For a patient with chronic nonmalignant pain, a prescriber, at a minimum and in addition to any additional requirements of the appropriate licensing board, shall:

(1)Check the prescriptive history of the patient on the Prescription Drug Monitoring Program at least every six (6) months; and (2) Have a signed pain contract with the patient that states, at a minimum, the expectations of the prescriber for the behavior of the patient which may include:

(A)A requirement for random urine drug screenings to help ensure that the patient is abiding by the requirements of the contract; and (B) A requirement for random pill counts to ensure compliance with the prescription.

(b)The requirements of this section shall not apply to a patient:

(1)Whose pain medications are being prescribed for a m

Free access — add to your briefcase to read the full text and ask questions with AI

(a) For a patient with chronic nonmalignant pain, a prescriber, at a minimum and in addition to any additional requirements of the appropriate licensing board, shall: (1) Check the prescriptive history of the patient on the Prescription Drug Monitoring Program at least every six (6) months; and (2) Have a signed pain contract with the patient that states, at a minimum, the expectations of the prescriber for the behavior of the patient which may include: (A) A requirement for random urine drug screenings to help ensure that the patient is abiding by the requirements of the contract; and (B) A requirement for random pill counts to ensure compliance with the prescription. (b) The requirements of this section shall not apply to a patient: (1) Whose pain medications are being prescribed for a malignant condition; (2) With a terminal condition; (3) Who is a resident of a licensed healthcare facility; (4) Who is enrolled in a hospice program; or (5) Who is in an inpatient or outpatient palliative care program.